|
Baseline Characteristics of HIV Patients in Study. |
|||
| Annexin levels at baseline |
Low |
High |
Total |
|
|
|||
| N |
7 |
7 |
14 |
| Age at randomization (years; mean) |
35 |
37 |
36 |
| Age at HIV diagnosis (year; mean) |
33 |
33 |
33 |
| Female (n) |
2 |
2 |
4 |
| Race |
|||
| Black (n) |
4 |
0 |
4 |
| White (n) |
1 |
2 |
3 |
| Hispanic (n) |
2 |
5 |
7 |
| Likely mode of infection*: |
|||
| Sexual contact, same sex (n) |
3 |
4 |
7 |
| Sexual contact, opposite sex (n) |
4 |
3 |
7 |
| Injection drug use(n) |
1 |
3 |
4 |
| CD4+ (cells/mm3; median) |
619 |
590 |
605 |
| CD4+ nadir (cells/mm3; median) |
384 |
203 |
219 |
| HIV RNA <500 copies/mL (n) |
6 |
7 |
13 |
| Time since first prescribed ART (months; median) |
14 |
20 |
17 |
| Hepatitis B co-infection (n) |
2 |
4 |
6 |
| Hepatitis B co-infection (n) |
1** |
1 |
2 |
| Hepatitis serology unknown (n) |
2 |
2 |
4 |
|
* Subjects reported more than one mode of infection. ** Subject co-infected with HBV and HCV. | |||
Lewis et al. Journal of Translational Medicine 2007 5:9 doi:10.1186/1479-5876-5-9 |
|||